Ubiquitin-specific protease 25: a new regulator for cardiovascular and cerebrovascular diseases
Frontiers in Cell and Developmental Biology · 23.07.2026 · 14
DOI: 10.3389/fcell.2026.1802539 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 23.07.2026. Verfasst von Yingchun Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Ubiquitin-specific protease 25 (USP25), a pivotal deubiquitinating enzyme, has attracted increasing attention in cardiovascular and cerebrovascular research due to its regulatory function in maintaining ubiquitination homeostasis. Considerable advances have been achieved in elucidating the molecular mechanisms through which USP25 participates in the pathological progression of diverse cardiovascular and cerebrovascular disorders. From the perspective of translational medicine, notable progress has also been observed in the development of USP25-targeted therapeutics, with several inhibitors having advanced to preclinical and early-phase clinical trials, thereby offering promising targets for precision treatment. Nevertheless, a systematic synthesis of fundamental biological properties, the trajectory of research development, and the intricate upstream–downstream regulatory networks of USP25, together with its mechanistic roles and therapeutic potential in these diseases, remains absent. In response, this review provides an in-depth summary of the essential biological features of USP25, elucidates the interplay between its upstream regulators and downstream substrates, and highlights its specific molecular mechanisms in cardiovascular and cerebrovascular disease pathogenesis. Additionally, the feasibility and strategic approaches of targeting USP25 for therapeutic purposes are analyzed, while the limitations and potential breakthroughs in the development of USP25 inhibitors are discussed. Finally, priority research directions are proposed to guide future exploration, with the ultimate aim of contributing theoretical foundations and novel perspectives for clinical management of cardiovascular and cerebrovascular diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Shao, Y., Jiang, S., Zhai, L., & Sun, F. (2026). Ubiquitin-specific protease 25: a new regulator for cardiovascular and cerebrovascular diseases. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1802539
Vancouver
Shao Y, Jiang S, Zhai L, Sun F. Ubiquitin-specific protease 25: a new regulator for cardiovascular and cerebrovascular diseases. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1802539
BibTeX
@article{Shao2026,
author = {Shao, Yingchun and Jiang, Shan and Zhai, Li and Sun, Fusheng},
title = {Ubiquitin-specific protease 25: a new regulator for cardiovascular and cerebrovascular diseases},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1802539}
}
EUVIMED